By using the R11-NLS CPP, we were able to show that targeting intracellular PCNA by pep8 can lead to cell death; however, the R11-NLS CPP is not specific to cancer cells and in vivo may facilitate peptide penetration to non-cancer cells and harm non-cancer proliferating cells such as activated immune cells. This evidence concerns the gene PCNA and cancer.